Call documents

CALL 2011 TEXT (PDF)

CALL 2011 GUIDELINES (PDF)

CALL 2011 PROPOSAL TEMPLATE (DOC)


Statistics

EuroNanoMed I call statistics

EuroNanoMed I call statistics

During the period 2009-2011, the ERA-NET EuroNanoMed I has successfully organized 3 joint calls for proposals. EuroNanoMed I funded 24 transnational research projects on nanomedicine involving 126 partners from 19 countries/regions, with € 25 million funding from the EuroNanoMed I partners and a further € 21 million funding from the research partners participating in the funded projects. This represents an important leverage effect for EuroNanoMed I:

x 18.8 if the funding of research projects from the EuroNanoMed I partners (€ 1 in Framework programme funding results in € 18.8 euro funding implemented by ERA-NETs) is taken into account; or

x 34.6 if we include the funding from the research partners participating in the funded projects.

Country of origin of the applicants

Altogether, 502 partners from more than 17 countries participated in these calls, in a total of 98 submitted projects. The number of applicants per country is presented in figure 1. As presented here, the number of applicants has grown in between 2009 and 2011, from 24 to 41 submitted proposals at each call.

ENMI JTC STATISTICS A

Figure 1: Number of applicants per country for each EuroNanoMed I joint call for proposals. ‘Non participating country’ refers to applicants that belonged to countries where no funding organization participated in the joint transnational call.

Success rates

The table below recapitulates the outcomes of each EuroNanoMed I call:

JTC-2009

JTC-2010

JTC-2011

Number of submitted proposals

24

33

41

Number of funded projects

8

8

8

Total costs of funded projects (M€)

16.9

15.9

13.3

Allocated funding (M€)

9

8

8

Success rate (%)

33

24

20

 

Participation of research organizations in translational projects in Nanomedecine

As EuroNanoMed I joint calls for proposals aimed at funding transnational research projects in Nanomedicine, each funded consortium had to include teams from at least 2 of the following categories: academia, industry, clinic/public health. The distribution between these three categories among funded consortia is outlined in Figure 2. Noteworthy, 62% of the funded projects included partners from all three categories, indicating the high added value of these collaborations in nanomedicine translational research.

ENMI JTC STATISTICS B

Figure 2: Type of research organizations funded through the three EuroNanoMed I joint calls for proposals.

Scientific / technological areas covered by funded projects

The three EuroNanoMed I joint calls for proposals were open to proposals covering at least one of the three priority topics of the European Technology Platform Nanomedecine: Targeted delivery systems, Diagnostics, Regenerative medicine. The coverage of these three scientific / technological areas among funded projects is presented in figure 3.

ENMI JTC STATISTICS C

Figure 3: Distribution of scientific / technological areas covered by funded projects in each of the three EuroNanoMed I joiny calls.